These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2749166)
1. [Changes in the locomotor system in inflammatory intestinal diseases. III. Clinical aspects of seronegative spondyloarthritis]. Zitová V; Streda A Sb Lek; 1989 Mar; 91(2-3):67-72. PubMed ID: 2749166 [TBL] [Abstract][Full Text] [Related]
2. Autoimmune disorders in patients affected by celiac sprue and inflammatory bowel disease. Bardella MT; Elli L; De Matteis S; Floriani I; Torri V; Piodi L Ann Med; 2009; 41(2):139-43. PubMed ID: 18777226 [TBL] [Abstract][Full Text] [Related]
3. [Changes in the locomotor system in inflammatory intestinal diseases. II. Clinical aspects of seronegative spondyloarthritis]. Zitová V; Fric P; Streda A; Kolár J Sb Lek; 1988 May; 90(5):140-6. PubMed ID: 3261882 [No Abstract] [Full Text] [Related]
4. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif]. Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976 [TBL] [Abstract][Full Text] [Related]
5. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study. Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV; Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963 [TBL] [Abstract][Full Text] [Related]
6. [Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group]. Flamenbaum M; Zénut M; Aublet-Cuvelier B; Larpent JL; Fabre P; Abergel A; Dapoigny M; Bommelaer G Gastroenterol Clin Biol; 1997; 21(6-7):491-6. PubMed ID: 9295977 [TBL] [Abstract][Full Text] [Related]
7. [Extra-intestinal Manifestations of chronic inflammatory Bowel diseases]. Pierer M; Krause C; Häntzschel H Z Gastroenterol; 2002 Apr; 40 Suppl 1():S92-S4. PubMed ID: 11930300 [TBL] [Abstract][Full Text] [Related]
8. [Extra-intestinal manifestation of IBD in Veszprém county (of Hungary): results of a 25-years follow-up study]. Lakatos L; Pandur T; Dávid G; Balogh Z; Küronya P; Tollas A; Lakatos PL Orv Hetil; 2003 Oct; 144(40):1965-75. PubMed ID: 14626638 [TBL] [Abstract][Full Text] [Related]
9. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279 [TBL] [Abstract][Full Text] [Related]
10. Gut and spondyloarthropathies. Leirisalo-Repo M; Repo H Rheum Dis Clin North Am; 1992 Feb; 18(1):23-35. PubMed ID: 1561404 [TBL] [Abstract][Full Text] [Related]
11. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784 [TBL] [Abstract][Full Text] [Related]
12. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association]. von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123 [TBL] [Abstract][Full Text] [Related]
13. The cause of death in inflammatory bowel disease: a comparison of death certificates and hospital charts in Rochester, New York. Nordenholtz KE; Stowe SP; Stormont JM; Stowe MM; Chessin LN; Shah AN; Chey WY Am J Gastroenterol; 1995 Jun; 90(6):927-32. PubMed ID: 7771423 [TBL] [Abstract][Full Text] [Related]
14. Clinical features of inflammatory joint and spine manifestations in Crohn's disease. Münch H; Purrmann J; Reis HE; Bertrams J; Zeidler H; Stolze T; Miller B; Korsten S; Cremers J; Strohmeyer G Hepatogastroenterology; 1986 Jun; 33(3):123-7. PubMed ID: 3488946 [TBL] [Abstract][Full Text] [Related]
15. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Bernstein CN; Wajda A; Blanchard JF Gastroenterology; 2005 Sep; 129(3):827-36. PubMed ID: 16143122 [TBL] [Abstract][Full Text] [Related]
17. Review article: joint involvement in inflammatory bowel disease. De Vos M Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():36-42. PubMed ID: 15352892 [TBL] [Abstract][Full Text] [Related]
18. Finnish patients with inflammatory bowel disease have fewer symptoms and are more satisfied with their treatment than patients in the previous European survey. Haapamäki J; Turunen U; Roine RP; Färkkilä MA; Arkkila PE Scand J Gastroenterol; 2008; 43(7):821-30. PubMed ID: 18584521 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of vasoactive intestinal peptide receptor 1 expression in inflammatory bowel disease. Yukawa T; Oshitani N; Yamagami H; Watanabe K; Higuchi K; Arakawa T Int J Mol Med; 2007 Aug; 20(2):161-7. PubMed ID: 17611633 [TBL] [Abstract][Full Text] [Related]